- Record: found
- Abstract: found
- Article: found
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
Dean Kereiakes, Jennifer Robinson, Christopher Cannon, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, Helen Colhoun
2015-06-01
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.